Phase 1 Respiratory syncytial virus Clinical Trials
8 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–8 of 8 trials
Recruiting
Phase 1
Study of Different Formulations of Vaccines Encoding the RSV Monovalent Antigen or the Flu H5 Antigen in Participants 18 to 49 Years of Age
Respiratory Syncytial Virus (RSV)Influenza A(H5N1)
Sanofi570 enrolled6 locationsNCT07516418
Recruiting
Phase 1Phase 2
A Study of BLB-201 RSV Vaccine in Infants and Children
Respiratory Syncytial Virus Infections
Blue Lake Biotechnology Inc.137 enrolled11 locationsNCT05655182
Recruiting
Phase 1Phase 2
Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm for the Treatment of Acute Respiratory Distress Syndrome (ARDS) Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)
SARS CoV-2Respiratory distress syndromeInfluenza, Human+1 more
PEACHES BIOTECH50 enrolled1 locationNCT06684379
Recruiting
Phase 1
First-in-human Safety and Immunogenicity Study of SCB-1022 and SCB-1033 in Healthy Older Adults
Respiratory Syncytial Virus VaccinationHuman Metapneumovirus VaccinationParainfluenza Vaccination
Clover Biopharmaceuticals AUS Pty192 enrolled1 locationNCT06984094
Recruiting
Phase 1Phase 2
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Recombinant Respiratory Syncytial Virus Vaccine
Respiratory syncytial virus
Sinocelltech Ltd.480 enrolled2 locationsNCT06754605
Recruiting
Phase 1
A Study to Describe the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine IN006 in Healthy Adult Aged 18 Years and Above
Respiratory Syncytial Virus Infections
Shenzhen Shenxin Biotechnology Co., Ltd240 enrolled2 locationsNCT06645665
Completed
Phase 1
A DDI Study to Evaluate the Effects of Itraconazole and Fluoxetine on AK0529 in Healthy Volunteers
Respiratory Syncytial Virus Infection
Ark Biosciences Pty Ltd28 enrolled1 locationACTRN12619001413112
Completed
Phase 1
A first in human study to evaluate the safety and immune response to a vaccine for the treatment of a respiratory virus, when administered into the arm in healthy adult participants.
Respiratory Syncytial Virus Infection
Advanced Vaccine Laboratories Pty Ltd60 enrolled1 locationACTRN12618000948291